✦ LIBER ✦

Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts

✍ Scribed by Razonable, Raymund R ;Paya, Carlos V

Book ID: 121209294
Publisher: Expert Reviews
Year: 2004
Tongue: English
Weight: 264 KB
Volume: 2
Category: Article
ISSN: 1478-7210
DOI: 10.1586/14787210.2.1.27

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valganciclovir: oral prevention and trea

Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host

✍ Freeman, Richard B 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 153 KB

Valganciclovir as Treatment for Cytomega

Valganciclovir as Treatment for Cytomegalovirus Disease in Solid Organ Transplant Recipients

✍ Len, O.; Gavalda, J.; Maria Aguado, J.; Borrell, N.; Cervera, C.; Miguel Cisnero 📂 Article 📅 2008 🏛 University of Chicago Press 🌐 English ⚖ 261 KB

Efficacy of Valganciclovir in the Treatm

Efficacy of Valganciclovir in the Treatment of Cytomegalovirus Disease in Kidney and Pancreas Transplant Recipients

✍ F.L. Luan; P. Chopra; J. Park; S. Norman; D. Cibrik; A. Ojo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A Trial of Valganciclovir Prophylaxis fo

A Trial of Valganciclovir Prophylaxis for Cytomegalovirus Prevention in Lung Transplant Recipients

✍ Atul Humar; Deepali Kumar; Jutta Preiksaitis; Guy Boivin; Deborah Siegal; Jayne 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Efficacy and Safety of Valganciclovir vs

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

✍ Carlos Paya; Atul Humar; Ed Dominguez; Kenneth Washburn; Emily Blumberg; Barbara 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Efficacy and safety of low-dose valganci

Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients

✍ Jeong M. Park; Kathleen D. Lake; Juan D. Arenas; Robert J. Fontana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

The efficacy and safety of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant recipients has not been established. We retrospectively compared the efficacy and safety of low-dose oral VGCV (450 mg once daily for 90 days) and standard oral ganciclovir (1 g three times a d